10% Discount on Manual & Electric Hospital Beds - Starting from 3 July!

MediGear Ltd

GE Senographe Pristina 3D

  1. Home
  2. Shop
  3. Medical Diagnostic Equipment
  4. GE Senographe Pristina 3D
✓ Certified Professional Seller GE Senographe Pristina 3D
GE Senographe Pristina 3D
GE HealthCare Medical Diagnostic Equipment

GE Senographe Pristina 3D

Personalised 3D Breast Imaging with Comfort, Precision, and Confidence.

The GE Senographe Pristina 3D is a patient-centred digital breast tomosynthesis system for hospital women's health centres, dedicated breast imaging clinics, and mammography screening services. With Pristina Dueta patient-assisted compression, ASIR DBT reconstruction, low DBT dose equivalent to 2D FFDM, and rounded detector corners, the GE Senographe Pristina 3D supports modern breast cancer screening. Available at Medigear.uk.

Sections
Mammography Unit
Categories
Medical Diagnostic Equipment
Condition
Good
Origin
Poland
Seller Type
Certified Professional Seller
CE & ISO Certified
Global Shipping
Supplier: Medigear
Share: Facebook LinkedIn Twitter Pinterest

The GE Senographe Pristina 3D is a patient-centred digital breast tomosynthesis (DBT) mammography system from GE HealthCare, engineered for hospital women's health centres, dedicated breast imaging clinics, mammography screening services, breast diagnostic centres, and multispecialty radiology departments. The Pristina platform combines 3D image quality, patient-assisted compression, and ergonomic design across screening, diagnosis, treatment planning, and monitoring along the breast care pathway worldwide.

The 3D tomosynthesis modality is the imaging foundation. The 25° sweep angle with 9 projections between −160° and +160° rotation captures detailed breast tissue volumes, while the "Step and Shoot" tube motion stops for each exposure to avoid image blur. Mo and Rh tube tracks create narrow X-ray spectra optimised for thin (Mo) and medium-to-thick breasts (Rh). The Pristina is the only FDA-approved 3D mammography system delivering DBT view dose equivalent to a 2D FFDM standard exposure.

Detector technology is engineered for precision and patient comfort. The 24×31 cm detector with 100 micron pixel pitch and no binning achieves a high DQE of 65% at 0.5 lp/mm and 57% at 2 lp/mm at 5 µGy. ASIR DBT iterative reconstruction with calcification artifact correction reconstructs images automatically, while the rounded detector corners reduce patient discomfort under the arms. Single-mouse-click switching between 2D and DBT modes, automatic exposure control, and anti-scatter grid use in tomosynthesis support efficient daily mammography workflow.

The Pristina Dueta hand-held wireless remote control enables patient-assisted compression — IPSOS data show 74% of patients who used Pristina Dueta were more likely to return for their next mammogram. Flex paddle tilts adapt to patient morphology, while the implant paddle accommodates women with implants or smaller breasts. V-Preview synthesized 2D images from DBT, eContrast HD processing, six-level real-time image contrasting, and upgradeable contrast-enhanced spectral mammography and biopsy capability extend Pristina utility across breast imaging programmes worldwide.

Pristina Dueta Patient-Assisted Compression

The Pristina Dueta hand-held wireless remote enables patient-assisted compression during mammography. IPSOS data show 74% of patients who used Dueta were more likely to return for their next mammogram, supporting screening compliance and patient experience.

Lowest DBT Dose Equivalent to 2D

The Senographe Pristina is the only FDA-approved 3D mammography system delivering DBT view dose equivalent to a 2D FFDM standard exposure. The Pristina emits the lowest patient dose of all FDA-approved 3D mammography devices.

3D Tomosynthesis with 25° Sweep

The 3D tomosynthesis modality features a 25° sweep angle with 9 projections between −160° and +160° rotation. The "Step and Shoot" tube motion stops for each exposure to avoid image blur, supporting detailed breast tissue volume reconstruction.

ASIR DBT Iterative Reconstruction

ASIR DBT iterative reconstruction with calcification artifact correction reconstructs DBT images automatically. The advanced reconstruction reduces propagation artifacts from clips and microcalcifications, supporting confident lesion characterisation across mammography workflows.

Rounded Detector with 100 Micron Pitch

The 24×31 cm detector with 100 micron pixel pitch and no binning achieves DQE of 65% at 0.5 lp/mm and 57% at 2 lp/mm at 5 µGy. Rounded detector corners reduce patient discomfort under the arms during examination.

Mo and Rh Tube Tracks

Mo and Rh tube tracks create narrow X-ray spectra optimised for breast density. Mo tracks support dose efficiency in thin breasts; Rh tracks support medium-to-thick breasts. The Artemis rotating anode tube delivers reliable acquisition.

Single-Click 2D and DBT Switching

Single-mouse-click switching between 2D mammography and DBT modes simplifies daily workflow. Automatic exposure control, anti-scatter grid use in tomosynthesis, V-Preview synthesized 2D images, eContrast HD processing, and six-level real-time image contrasting streamline radiologist reading.

Breast Cancer Screening

The GE Senographe Pristina 3D anchors breast cancer screening across hospital women's health centres, dedicated mammography screening services, and breast imaging clinics. DBT view dose equivalent to 2D FFDM, Pristina Dueta patient-assisted compression, V-Preview synthesized 2D, and 74% improved patient return rates support screening compliance and early detection across busy mammography programmes worldwide today.

Diagnostic Mammography

Diagnostic mammography benefits substantially from the Pristina's 3D tomosynthesis with 25° sweep angle, ASIR DBT reconstruction with calcification artifact correction, six-level real-time image contrasting, and eContrast HD 2D processing. Detailed lesion characterisation, microcalcification assessment, and architectural distortion evaluation support confident diagnosis across breast diagnostic services worldwide today.

Dense Breast Imaging

Dense breast imaging benefits from the Pristina's 3D tomosynthesis tissue separation, Rh tube tracks for medium-to-thick breasts, and ASIR DBT reconstruction. Improved lesion conspicuity in dense breast tissue, reduced overlap-related false positives, and supplemental screening capability support women with mammographically dense breasts across breast imaging services worldwide.

Breast Implant and Post-Surgical Imaging

Breast implant and post-surgical imaging benefit from the Pristina's dedicated implant paddle, flex paddle tilts adapting to patient morphology, and ergonomic detector with rounded corners. The platform accommodates women with breast implants, post-augmentation patients, and post-mastectomy reconstruction patients across hospital and breast imaging clinic services worldwide today during routine practice.

Contrast-Enhanced Spectral Mammography

Contrast-enhanced spectral mammography (CESM) capability is available as an upgrade for the Senographe Pristina platform. CESM supports problem-solving in equivocal cases, neoadjuvant treatment monitoring, and supplemental screening in women with dense breasts across breast diagnostic centres seeking advanced functional breast imaging worldwide today during routine practice in busy multidisciplinary breast imaging programmes.

For Women's Health Centres and Breast Clinics

The GE Senographe Pristina 3D brings patient-centred DBT mammography to hospital women's health centres, dedicated breast imaging clinics, and mammography screening services through Pristina Dueta patient-assisted compression, lowest-dose DBT equivalent to 2D FFDM, ASIR DBT reconstruction, and ergonomic rounded detector. CE-aligned manufacturing, FDA approval, V-Preview synthesized 2D, and GE HealthCare service support meet stringent procurement compliance across screening and diagnostic services worldwide today during routine clinical practice.

For Hospital Radiology and Diagnostic Programmes

The Pristina supports hospital radiology departments, multispecialty diagnostic centres, and breast diagnostic programmes through 3D tomosynthesis with 25° sweep angle, single-click 2D/DBT switching, eContrast HD processing, six-level real-time contrasting, and upgradeable CESM and biopsy capability. Reliable GE HealthCare engineering and broad clinical applicability support integration across hospital screening, diagnostic, and intervention services worldwide today during daily clinical workflows in multidisciplinary breast care programmes.

For Medical Equipment Distributors

GE HealthCare is a globally established mammography manufacturer with strong brand recognition, comprehensive training resources, expert technical support, and reliable after-sales service networks worldwide. Distributors partnering with Medigear.uk gain access to a complete Senographe Pristina ecosystem supported by detailed documentation, warranty coverage, parts availability, and refurbished inventory. Sustained Pristina demand drives consistent distribution value across breast imaging, women's health, screening, and diagnostic mammography channels worldwide today across hospital networks.

The GE Senographe Pristina 3D mammography system is a clinically proven patient-centred breast imaging tool combining digital breast tomosynthesis with 25° sweep angle and 9 projections, "Step and Shoot" tube motion, Mo and Rh tube tracks for dose efficiency, the Artemis rotating anode tube, 24×31 cm detector with 100 micron pixel pitch, ASIR DBT iterative reconstruction with calcification artifact correction, Pristina Dueta wireless patient-assisted compression remote, lowest FDA-approved 3D mammography dose equivalent to 2D FFDM, single-mouse-click 2D/DBT switching, V-Preview synthesized 2D, eContrast HD processing, six-level real-time contrasting, flex paddle tilts, dedicated implant paddle, and upgradeable CESM and biopsy capability in one patient-centred platform. Its CE-aligned manufacturing, FDA approval, and proven GE HealthCare service network serve women's health centres, breast imaging clinics, and mammography screening services seeking patient-centred 3D mammography. Whether deployed for screening or diagnosis, the Pristina delivers imaging teams demand. Contact Medigear.uk for the Pristina today.

FAQ

Frequently Asked Questions

Everything buyers need to know about sourcing medical equipment through MediGear.

The GE Senographe Pristina 3D is a digital breast tomosynthesis (DBT) mammography system used for breast cancer screening, diagnostic mammography, dense breast imaging, breast implant imaging, and contrast-enhanced spectral mammography. It serves hospital women's health centres, dedicated breast imaging clinics, and mammography screening programmes worldwide.

Pristina Dueta is a hand-held wireless remote control that enables patient-assisted compression during mammography. The patient actively participates in compression while the technologist retains full control, supporting reduced anxiety and pain. IPSOS data show 74% of users were more likely to return for their next mammogram.

The Senographe Pristina is the only FDA-approved 3D mammography system delivering a DBT view dose equivalent to a 2D FFDM standard exposure. The Pristina emits the lowest patient dose of all FDA-approved 3D mammography devices, supporting dose-conscious screening across mammography programmes worldwide.

ASIR DBT is GE HealthCare's iterative reconstruction algorithm for digital breast tomosynthesis. ASIR DBT features calcification artifact correction that reduces propagation artifacts from clips and microcalcifications, supporting confident lesion characterisation and diagnostic accuracy across screening and diagnostic mammography workflows worldwide.

The Senographe Pristina 3D features a 25° sweep angle with 9 projections between −160° and +160° rotation. The "Step and Shoot" tube motion stops for each exposure to avoid image blur, supporting detailed breast tissue volume reconstruction across diverse breast morphology and density patterns.

The Pristina features a 24×31 cm detector with 100 micron pixel pitch and no binning. The detector achieves DQE of 65% at 0.5 lp/mm and 57% at 2 lp/mm at 5 µGy in 3D mode. Rounded detector corners reduce patient discomfort under the arms during examination.

The Pristina uses Mo and Rh tube tracks creating narrow X-ray spectra optimised for breast density. Mo tracks support dose efficiency in thin breasts, while Rh tracks support medium-to-thick breasts. Two beam qualities (26 kV Mo/Mo, 34 kV Rh/Ag) deliver reliable acquisition across diverse patient populations.

Yes. The Senographe Pristina switches between 2D mammography and DBT modes with a single mouse click. Combined with automatic exposure control, anti-scatter grid use in tomosynthesis, V-Preview synthesized 2D from DBT, and eContrast HD processing, the platform supports streamlined daily mammography workflow.

The Pristina includes flex paddle tilts that adapt to patient morphology for adaptive examination positioning, plus a dedicated implant paddle for women with breast implants or smaller breasts. The paddle range supports diverse patient anatomies and breast types across screening and diagnostic mammography services worldwide today.

Yes. The Senographe Pristina is upgradeable to support contrast-enhanced spectral mammography (CESM) and breast biopsy in a dynamic environment. The upgrade pathway extends Pristina utility across problem-solving, neoadjuvant monitoring, supplemental screening, and image-guided breast intervention workflows across modern breast imaging programmes.

Medigear.uk supports site planning, installation, commissioning, and clinician training for the GE Senographe Pristina 3D. Training covers DBT acquisition protocols, Pristina Dueta workflow, ASIR DBT reconstruction, V-Preview interpretation, eContrast HD processing, dose management, and DICOM workflow via authorised GE HealthCare service partners worldwide.

Yes. Medigear.uk supports certified refurbished GE Senographe Pristina 3D procurement at cost-effective prices. Refurbished systems undergo comprehensive inspection, calibration, detector testing, tube verification, and quality control, providing a budget-friendly option for hospital women's health, breast imaging clinic, and mammography screening procurement programmes worldwide today.